President Donald Trump named a Maine official opposed to Medicaid expansion under the Affordable Care Act for a position that puts her in charge of the national program; an unvaccinated child in Florida has died from the flu, becoming the first person to die from the disease this season; Kaiser Health News has created a database to track up to 10 years of pharmaceutical company contributions to any or all members of Congress.
President Donald Trump named a Maine official opposed to Medicaid expansion under the Affordable Care Act for a position that puts her in charge of the national program, the Associated Press reported. Mary Mayhew's role of deputy administrator and director at CMS will place her in charge of the federal healthcare program for low-income people. She served as commissioner of Maine's Department of Health and Human Services for 7 years under Republican Gov. Paul LePage. Separately, the news service reported that Arkansas cut another 4100 people from their health insurance and another 4800 people will lose coverage at the end of the month for not meeting a new Medicaid work requirement.
An unvaccinated child in Florida has died from the flu, becoming the first person to die from the disease this season, The Hill reported. The child was diagnosed with influenza B and died sometime between September 30 and October 6, according to state health officials. The child had no underlying medical conditions, officials said. About 80% of the 80,000 people who died last year from the flu were unvaccinated, according to the CDC.
Kaiser Health News has created a database to track up to 10 years of pharmaceutical company contributions to any or all members of Congress, spotlighting drugmakers’ efforts to influence legislation. Kaiser reported that since the beginning of 2017, drugmakers contributed to 217 Republicans and 187 Democrats, giving only slightly more on average to Republicans, who currently control both chambers of Congress. This was also the case for Democrats during the 2010 election cycle, when they controlled Congress.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More